Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden
May 09
Polish (WIG) Pharma Industry Analysis
UpdatedMay 19, 2024
DataAggregated Company Financials
Companies5
- 7D2.6%
- 3M0.4%
- 1Y3.9%
- YTDn/a
In the last week, the Pharma industry is up 2.6%, with Celon Pharma up 4.5%. In the same time, Molecure was down 5.1%. This takes the industry's 12 month performance to a gain of 3.9%. As for the next few years, earnings are expected to grow by 75% per annum.
Industry Valuation and Performance
Has the Polish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 19 May 2024 | zł1.2b | zł311.0m | -zł43,187,309.00 | 13.1x | -27.9x | 3.9x |
| Tue, 16 Apr 2024 | zł1.1b | zł311.5m | -zł40,173,065.00 | 15.1x | -28.3x | 3.6x |
| Thu, 14 Mar 2024 | zł1.2b | zł311.5m | -zł40,173,065.00 | 15.2x | -30x | 3.9x |
| Sat, 10 Feb 2024 | zł1.2b | zł308.7m | -zł39,880,934.00 | 18x | -30.1x | 3.9x |
| Mon, 08 Jan 2024 | zł1.2b | zł308.7m | -zł39,880,934.00 | 11.7x | -30.1x | 3.9x |
| Wed, 06 Dec 2023 | zł1.2b | zł308.7m | -zł39,880,934.00 | 11.2x | -30.5x | 3.9x |
| Fri, 03 Nov 2023 | zł1.1b | zł302.0m | -zł44,782,495.00 | 11.2x | -24.7x | 3.7x |
| Sun, 01 Oct 2023 | zł1.1b | zł302.0m | -zł42,933,291.00 | 10.5x | -26.2x | 3.7x |
| Tue, 29 Aug 2023 | zł1.3b | zł287.0m | -zł53,882,152.00 | 11.4x | -23.4x | 4.4x |
| Thu, 27 Jul 2023 | zł1.2b | zł278.4m | -zł53,806,540.00 | 37.1x | -22.2x | 4.3x |
| Sat, 24 Jun 2023 | zł1.2b | zł278.4m | -zł53,806,540.00 | 36.7x | -22.1x | 4.3x |
| Mon, 22 May 2023 | zł1.1b | zł280.8m | -zł51,259,182.00 | 8.7x | -21.2x | 3.9x |
| Wed, 19 Apr 2023 | zł1.1b | zł273.2m | -zł44,427,333.00 | 8.9x | -24.9x | 4x |
| Fri, 17 Mar 2023 | zł1.1b | zł273.2m | -zł44,427,333.00 | 8.2x | -25x | 4.1x |
| Sun, 12 Feb 2023 | zł1.1b | zł270.3m | -zł44,201,704.00 | 7.7x | -25.9x | 4.2x |
| Tue, 10 Jan 2023 | zł1.0b | zł270.3m | -zł44,201,704.00 | 8x | -23x | 3.8x |
| Thu, 08 Dec 2022 | zł1.0b | zł270.3m | -zł44,201,704.00 | 7.6x | -22.8x | 3.7x |
| Sat, 05 Nov 2022 | zł978.0m | zł260.7m | -zł40,809,798.00 | 8.4x | -24x | 3.8x |
| Mon, 03 Oct 2022 | zł898.6m | zł261.1m | -zł40,391,998.00 | 9.1x | -22.2x | 3.4x |
| Wed, 31 Aug 2022 | zł1.0b | zł265.7m | -zł29,303,736.00 | 10.3x | -35.1x | 3.9x |
| Fri, 29 Jul 2022 | zł1.1b | zł264.2m | -zł29,985,890.00 | 11x | -37.1x | 4.2x |
| Sun, 26 Jun 2022 | zł1.0b | zł264.2m | -zł29,985,890.00 | 10x | -34.5x | 3.9x |
| Tue, 24 May 2022 | zł1.4b | zł269.1m | -zł24,188,890.00 | 10.6x | -56.5x | 5.1x |
| Thu, 21 Apr 2022 | zł1.7b | zł235.3m | -zł1,158,483.00 | 62.7x | -1497.1x | 7.4x |
| Sat, 19 Mar 2022 | zł1.8b | zł358.1m | zł72.0m | 12.7x | 25.5x | 5.1x |
| Mon, 14 Feb 2022 | zł2.0b | zł350.0m | zł71.4m | 18x | 28.1x | 5.7x |
| Wed, 12 Jan 2022 | zł2.3b | zł350.0m | zł71.4m | 14.6x | 31.8x | 6.5x |
| Fri, 10 Dec 2021 | zł2.2b | zł350.0m | zł71.4m | 14.8x | 31x | 6.3x |
| Sun, 07 Nov 2021 | zł2.6b | zł344.7m | zł81.6m | 11.2x | 31.9x | 7.5x |
| Tue, 05 Oct 2021 | zł2.4b | zł344.7m | zł82.7m | 11.4x | 29.4x | 7x |
| Thu, 02 Sep 2021 | zł2.6b | zł330.5m | zł86.5m | 11.4x | 30.1x | 7.9x |
| Sat, 31 Jul 2021 | zł2.5b | zł330.5m | zł86.5m | 10.4x | 28.5x | 7.4x |
Price to Earnings Ratio
33x
Current Industry PE
- Investors are pessimistic on the Polish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.9x is higher than the industry's current PS ratio of 3.9x.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have remained mostly flat.
- This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Polish Pharma compare with similar industries?
| PL Market | 1.58% | |
| Healthcare | 2.30% | |
| Pharma | 2.64% | |
| Pharma | 2.64% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CLN Celon Pharma | zł16.84 | 4.5% +zł36.8m | 14.1% | PS4x | |
| CBD Cannabis Poland | zł0.73 | 22.1% +zł6.5m | 114.7% | PS547.2x | |
| BGD Biogened | zł22.40 | 1.8% +zł982.5k | 60.0% | PE13.1x |